http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110330619-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L75-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-4854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-6674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-3221
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G18-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G18-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L75-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G18-48
filingDate 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110330619-B
titleOfInvention Medical polyurethane material containing lactone group, preparation method thereof and medical catheter
abstract The invention provides a medical polyurethane material containing lactone groups and a medical catheter prepared from the same. The medical polyurethane material is prepared by polycondensation of the following raw materials: 4, 4' -diphenylmethane diisocyanate, butanediol, polytetrahydrofuran and butyrolactone group-containing substances; the material containing butyrolactone groups at least contains two hydroxyl groups, and the molar mass concentration of the butyrolactone groups in the medical polyurethane material is 5-20 mmol/100 g. The lactone group of the medical polyurethane material provided by the invention is in a closed ring state in a dry state, the hydrophobicity of polyurethane can be kept, the extrusion molding of the polyurethane material is not influenced, the lactone group is subjected to a hydrolytic ring-opening reaction in an aqueous phase environment or in vivo, the hydrophilicity of the polyurethane material is increased, the elastic modulus of the polyurethane material is obviously reduced, the medical catheter prepared from the material has higher rigidity in vitro, and the softness is obviously increased after the medical catheter enters a blood vessel of a human body.
priorityDate 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415797151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419765613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419639549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73561

Total number of triples: 35.